In pancreatic cancer cells, IL-1β has been shown to mediate adhesion and invasion, as well as modulating chemoresistance by activating the NF- κB and ERK signaling pathways [120]–[123]. This evidence concerns the gene IL1B and familial pancreatic carcinoma.